Schrodinger (NASDAQ:SDGR) Hits New 52-Week Low – Should You Sell?

Schrodinger, Inc. (NASDAQ:SDGR) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $16.44 and last traded at $16.4350, with a volume of 359301 shares trading hands. The stock had previously closed at $16.85.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. The Goldman Sachs Group assumed coverage on shares of Schrodinger in a research report on Monday, September 29th. They set a “neutral” rating and a $19.00 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a research report on Tuesday, October 14th. Morgan Stanley cut their price target on Schrodinger from $28.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, August 18th. Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a report on Saturday, October 25th. Finally, Barclays initiated coverage on Schrodinger in a research report on Thursday, August 14th. They issued an “overweight” rating and a $25.00 target price for the company. Three analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Schrodinger currently has a consensus rating of “Hold” and a consensus price target of $26.00.

Schrodinger Price Performance

The firm’s fifty day simple moving average is $19.72 and its 200 day simple moving average is $20.74. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of -6.79 and a beta of 1.77.

Schrodinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.72) by $0.27. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. The business had revenue of $54.32 million for the quarter, compared to analyst estimates of $50.51 million. During the same quarter in the previous year, the business earned ($0.87) earnings per share. The firm’s revenue was up 53.9% compared to the same quarter last year. Schrodinger has set its FY 2025 guidance at EPS. Equities research analysts forecast that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Insider Activity at Schrodinger

In other news, insider Margaret Dugan sold 1,395 shares of Schrodinger stock in a transaction on Thursday, October 16th. The stock was sold at an average price of $21.07, for a total transaction of $29,392.65. Following the transaction, the insider owned 24,574 shares in the company, valued at approximately $517,774.18. The trade was a 5.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 21.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Schrodinger

Several institutional investors and hedge funds have recently bought and sold shares of the business. Farther Finance Advisors LLC lifted its position in shares of Schrodinger by 347.4% in the second quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock worth $26,000 after purchasing an additional 997 shares in the last quarter. Bayforest Capital Ltd bought a new position in Schrodinger in the second quarter valued at approximately $30,000. ANTIPODES PARTNERS Ltd acquired a new stake in Schrodinger during the 1st quarter worth $37,000. State of Wyoming bought a new stake in shares of Schrodinger during the 2nd quarter valued at $39,000. Finally, Aster Capital Management DIFC Ltd lifted its stake in Schrodinger by 212.4% in the third quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock valued at $39,000 after buying an additional 1,321 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.